Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study
This randomized controlled trial of low GDP vs standard peritoneal dialysis solutions concluded that low GDP solutions successfully preserved residual renal function.
See the accompanying editorial by Dr. Joanne Bargman for a critical analysis of the paper.
- Slouching towards Bethlehem: the beast of biocompatibility
- Preserving residual renal function in peritoneal dialysis: volume or biocompatibility?
- Effect of Neutral-pH, Low–Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis